AI-powered crystal structure prediction for small-molecule drug development
This is our editors' assessment out of 5, not an average of user ratings. The viewpoints on this page are written by AI from what we know about the product. They are not customer reviews.
According to OpenAITools.app telemetry verified on 2026-11-11, Lavo Life Sciences (lavo.ai) is an AI platform indexed under AI Predictions generating 0 monthly visits with a month-over-month traffic delta of +0 (0%). Its primary geographic market is Global (— traffic share), and it operates on a Contact for Pricing pricing model. Top competing alternatives by monthly volume include Intelligencia AI (3.87K visits/mo), Unlearn.AI (17.11K visits/mo), Citrine Informatics (7.77K visits/mo).
Saved weeks of solid-state screening.
Crystal Console UI is clean.
Enterprise pricing opaque as usual.
Fast.
AI-synthesized perspectives grounded in live site inspection, pricing structure, and category benchmarks — presented as editorial viewpoints rather than individual customer testimonials.
Import, visualize and analyze crystal structures through an intuitive browser-based interface.
Identify and analyze potential polymorphs computationally to flag solid-state risks early in development.
Upload, analyze and compare PXRD data against predicted structures to confirm forms faster.
Surface hidden or more desirable polymorphs that traditional experimental methods might miss.
Use predictions to support stability and manufacturability decisions that reduce development time and cost.
Drug development often hinges on the solid state of a molecule: which crystal form you get can affect stability, solubility, manufacturability and, ultimately, your timeline. Lavo Life Sciences applies AI-accelerated crystal structure prediction to small-molecule drugs so teams can anticipate those crystal forms earlier, de-risk their pipeline and optimize formulations before late-stage surprises appear.
The centerpiece is Crystal Console, a web-based platform for AI-powered crystallography. It brings together structure analysis, virtual polymorph screening and PXRD analysis in one interface: import and visualize structures, screen computationally for potential polymorphs, and upload experimental PXRD data to compare it against predicted structures.
The company is staffed by chemists and engineers who combine AI with computational chemistry know-how. Because its focus is decision support for pharmaceutical R&D, Lavo is positioned as a complement to laboratory work — helping teams discover novel polymorphs, mitigate risks and move more efficiently through the development pipeline.
Screen for potential polymorphs computationally to flag solid-state risks before committing to costly experiments.
Compare experimental PXRD patterns against predicted structures to identify and confirm crystal forms faster.
Use crystal structure insights to inform decisions about stability and manufacturability of drug candidates.
Explore predicted structures to spot novel or more desirable polymorphs that experimental methods may overlook.
Side-by-side telemetry comparison of competing AI tools in the same primary category
| Rank | AI Tool | Monthly Visits | MoM Growth | Direct traffic share | Pricing | Head-to-Head |
|---|---|---|---|---|---|---|
| ● | Lavo Life Sciences | 0 | 0% | — | Contact for Pricing | Current |
| 1 | Intelligencia AI | 3.87K | -31.9% | 27% direct | Contact for Pricing | vs Intelligencia AI |
| 2 | Unlearn.AI | 17.11K | -32.5% | 44% direct | Contact for Pricing | vs Unlearn.AI |
| 3 | Citrine Informatics | 7.77K | -1.2% | 40% direct | Contact for Pricing | vs Citrine Informatics |
| 4 | Cradle | 16.99K | -22.3% | 37% direct | Contact for Pricing | vs Cradle |
| 5 | Lotto Chart | 17.29K | +89.4% | 75% direct | Free | vs Lotto Chart |
| 6 | Floatz | 253 | -36.8% | 37% direct | Contact for Pricing | vs Floatz |
AI-powered probability-of-success analytics for clinical drug development
AI-powered probability-of-success analytics for clinical drug development
AI-generated digital twins that make clinical trials smaller, faster, and more informative
AI-generated digital twins that make clinical trials smaller, faster, and more informative
Materials and chemicals AI that turns messy lab data into faster product launches
Materials and chemicals AI that turns messy lab data into faster product launches
Engineer better proteins, faster, with AI
Free / Open-sourceSeven AI prediction models for charting and analysing lottery numbers
Free / Open-sourceSeven AI prediction models for charting and analysing lottery numbers
AI-driven scientific due diligence for biotech investors
AI-driven scientific due diligence for biotech investors
Cloud platform for design-of-experiments and lab automation that turns biological experiments into AI-ready data
Cloud platform for design-of-experiments and lab automation that turns biological experiments into AI-ready data
AI-powered ECG interpretation and precision cardiology at scale
Free / Open-sourceCalibrated forecasts with the evidence trail attached
Free / Open-sourceCalibrated forecasts with the evidence trail attached
AI-enabled literature review and evidence management platform trusted by top pharma and medical device teams
AI-enabled literature review and evidence management platform trusted by top pharma and medical device teams
Free / Open-sourceDaily AI price targets and forecasts for ~1,900 stocks
Free / Open-sourceDaily AI price targets and forecasts for ~1,900 stocks
Free / Open-sourceAI-powered resident care platform for senior living
Free / Open-sourceAI-powered resident care platform for senior living
